Merck Wins Second Fosamax Trial After Questioning Qualifications Of Expert Witness (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Idera, Novartis deal ends; Merck deal extended (Mass High Tech)
Johnson & Johnson Focused Funding Grant for Parkinson’s Research (Newswise)
Merck cholesterol scrips drop as Niaspan rises (FiercePharma)
NICE spurns Avastin for bowel cancer (Reuters)
BCGold Corp. Announces Board Changes (MarketWire)
Study results from University of Texas update understanding of education (Pharmacy Choice)
Inhaled Delivery of Systemic Drugs on Track to Approach $2 Billion in 2012 (Pharmacy Choice)
Merck to close warehouse, lay off 80: Upper Macungie operations will be moved to New Jersey. (The Morning Call)
Skymark Research Initiates Independent Research Coverage on Sequenom, Inc. (StreetInsider.com)
Abbott Laboratories Set New 52-Week High Tuesday (RTT News)
SUBSCRIBE